Taysha Gene Therapies logo

Taysha Gene Therapies share price today

(TSHA)

Taysha Gene Therapies share price is $2.05 & ₹175.91 as on 7 Jan 2025, 2.30 'hrs' IST

$2.05

0.13

(6.77%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Taysha Gene Therapies share price in Dollar and Rupees. Guide to invest in Taysha Gene Therapies stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Taysha Gene Therapies, along with analyst recommendations, forecasts, and comprehensive financials.

Taysha Gene Therapies share price movements

  • Today's Low: $1.88
    Today's High: $2.06

    Day's Volatility :8.74%

  • 52 Weeks Low: $1.19
    52 Weeks High: $4.32

    52 Weeks Volatility :72.45%

Taysha Gene Therapies Returns

PeriodTaysha Gene Therapies IncSector (Health Care)Index (Russel 2000)
3 Months
-4.48%
-8.4%
0.0%
6 Months
-14.29%
-3.8%
0.0%
1 Year
4.35%
-0.1%
0.0%
3 Years
-81.5%
2.9%
-19.8%

Taysha Gene Therapies Key Statistics

in dollars & INR

Previous Close
$1.92
Open
$1.93
Today's High
$2.06
Today's Low
$1.88
Market Capitalization
$354.6M
Today's Volume
$1.3M
52 Week High
$4.32
52 Week Low
$1.19
Revenue TTM
$9.9M
EBITDA
$-81.2M
Earnings Per Share (EPS)
$0.63
PE Ratio
2.75
Profit Margin
-229.67%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-114.77%

How to invest in Taysha Gene Therapies from India?

It is very easy for Indian residents to invest directly in Taysha Gene Therapies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Taysha Gene Therapies stock in both Indian Rupees (INR) and US Dollars (USD). Search for Taysha Gene Therapies or TSHA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Taysha Gene Therapies or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Taysha Gene Therapies shares which would translate to 0.419 fractional shares of Taysha Gene Therapies as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Taysha Gene Therapies, in just a few clicks!

Returns in Taysha Gene Therapies for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Taysha Gene Therapies investment value today

Current value as on today

₹1,14,636

Returns

₹14,636

(+14.64%)

Returns from Taysha Gene Therapies Stock

₹11,413 (+11.41%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Taysha Gene Therapies

-43%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Taysha Gene Therapies on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -43% less investors are searching Taysha Gene Therapies in the last 30 days versus the previous period.

Global Institutional Holdings in Taysha Gene Therapies

  • FMR Inc

    9.11%

  • venBio Select Advisor LLC

    9.10%

  • RTW INVESTMENTS, LLC

    7.29%

  • BlackRock Inc

    5.73%

  • RA Capital Management, LLC

    5.31%

  • VR Adviser, LLC

    4.39%

Analyst Recommendation on Taysha Gene Therapies

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Taysha Gene Therapies(by analysts ranked 0 to 5 stars)

Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
13
13
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Taysha Gene Therapies

What analysts predicted

Upside of 221.51%

Current:

$2.05

Target:

$6.59

Insights on Taysha Gene Therapies

  • Price Movement

    In the last 7 days, TSHA stock has moved up by 11.0%
  • TSHA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 15.8%
  • TSHA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 137.6%
  • Price to Sales

    ForTSHA every $1 of sales, investors are willing to pay $45.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Taysha Gene Therapies Technicals Summary

Sell

Neutral

Buy

Taysha Gene Therapies is currently in a neutral trading position according to technical analysis indicators.

Taysha Gene Therapies Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Taysha Gene Therapies Inc
-25.0%
-14.29%
4.35%
-81.5%
-92.02%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Taysha Gene Therapies Inc
2.75
2.75
NA
-0.31
-1.15
-0.27
NA
0.33
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Taysha Gene Therapies Inc
Buy
$354.6M
-92.02%
2.75
-229.67%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Taysha Gene Therapies

taysha gene therapies, inc., a gene therapy company, develops adeno-associated virus based gene therapies for the treatment of monogenic diseases of the central nervous system. it primarily develops tsha-101 for the treatment of gm2 gangliosidosis; tsha-118 for the treatment of cln1 disease; tsha-102 for the treatment of rett syndrome; tsha-103 for the treatment of slc6a1 haploinsufficiency disorder; and tsha-104 for the treatment for surfeit locus 1 deficiency. the company also has strategic partnership with the university of texas southwestern medical center to develop and commercialize transformative gene therapy treatments. taysha gene therapies, inc. was founded in 2019 and is based in dallas, texas.
Organization
Taysha Gene Therapies
Employees
52
CEO
Mr. Sean P. Nolan
Industry
Health Technology

Management People of Taysha Gene Therapies

NameTitle
Mr. Sean P. Nolan
CEO & Chairman
Dr. Sukumar Nagendran M.D.
President, Head of Research & Development and Director
Mr. Kamran Alam CPA, M.B.A.
CFO & Corporate Secretary
Hayleigh Collins
Director of Corporate Communications & Investor Relations
Ms. Tracy M. Porter SPHR
Chief People Officer
Mr. Frederick Porter Ph.D.
Chief of Staff & Technical Operations Officer
Ms. Emily McGinnis M.P.H.
Chief Patient & External Affairs Officer and Endpoint & Outcome Development Lead
Mr. Sean McAuliffe
Chief Business Officer
Dr. Steven Gray Ph.D.
Chief Scientific Advisor of UT Southwestern Gene Therapy Program
Berge Minassian M.D.
Chief Medical Advisor of UT Southwestern Gene Therapy Program

Important FAQs about investing in Taysha Gene Therapies from India :

What is Taysha Gene Therapies share price today?

Taysha Gene Therapies share price today stands at $2.05, Open: $1.93 ; Previous Close: $1.92 ; High: $2.06 ; Low: $1.88 ; 52 Week High: $4.32 ; 52 Week Low: $1.19. The stock opens at $1.93, after a previous close of $1.92. The stock reached a daily high of $2.06 and a low of $1.88, with a 52-week high of $4.32 and a 52-week low of $1.19.

Can Indians buy Taysha Gene Therapies shares?

Yes, Indians can invest in the Taysha Gene Therapies (TSHA) from India.

With INDmoney, you can buy Taysha Gene Therapies at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Taysha Gene Therapies at zero transaction cost.

How can I buy Taysha Gene Therapies shares from India?

It is very easy to buy Taysha Gene Therapies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Taysha Gene Therapies be purchased?

Yes, you can buy fractional shares of Taysha Gene Therapies with INDmoney app.

What are the documents required to start investing in Taysha Gene Therapies stocks?

To start investing in Taysha Gene Therapies, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Taysha Gene Therapies

Today’s highest price of Taysha Gene Therapies (TSHA) is $2.06.

Today’s lowest price of Taysha Gene Therapies (TSHA) is $1.88.

What is today's market capitalisation of Taysha Gene Therapies

Today's market capitalisation of Taysha Gene Therapies TSHA is 354.6M

What is the 52 Week High and Low Range of Taysha Gene Therapies

  • 52 Week High

    $4.32

  • 52 Week Low

    $1.19

What are the historical returns of Taysha Gene Therapies?

  • 1 Month Returns

    -25%

  • 3 Months Returns

    -14.29%

  • 1 Year Returns

    4.35%

  • 5 Years Returns

    -92.02%

Who is the Chief Executive Officer (CEO) of Taysha Gene Therapies

Mr. Sean P. Nolan is the current Chief Executive Officer (CEO) of Taysha Gene Therapies.